STAT3 and central nervous system cancer: In turn, EGFR triggers the activation of signalling cascades impinging on signal transducer and activator of transcription 3 (STAT3), AKT, and the mitogen-activated protein kinases (MAPKS) ERK1/2, thereby promoting the oncogenic phenotype of glioma cells.